Systematic Review: Models of Changes in Gene Expression of MTOR, MURF-1, and MAFBX in Rats and Mice.
Amino Acid Metabolism, Inborn Errors
/ genetics
Animals
Arrhythmias, Cardiac
/ genetics
Atrophy
/ genetics
Burns
/ genetics
Disease Models, Animal
Gene Expression Regulation
/ genetics
Humans
Mice
Muscle Proteins
/ genetics
Neoplasms
/ genetics
Rats
SKP Cullin F-Box Protein Ligases
/ genetics
Sepsis
/ genetics
TOR Serine-Threonine Kinases
/ genetics
Tripartite Motif Proteins
/ genetics
Ubiquitin-Protein Ligases
/ genetics
Journal
Critical reviews in eukaryotic gene expression
ISSN: 1045-4403
Titre abrégé: Crit Rev Eukaryot Gene Expr
Pays: United States
ID NLM: 9007261
Informations de publication
Date de publication:
2020
2020
Historique:
entrez:
19
5
2020
pubmed:
19
5
2020
medline:
15
7
2021
Statut:
ppublish
Résumé
Various pathologies and lifestyle factors, such as nutritional factors and physical exercises, can alter the gene expression of proteins related to synthesis and degradation. We performed a systematic review of atrophy models, cancer models, burn models, sepsis models, cardiac insufficiency models, amino acid supplementation models, protein supplementation models, and miscellaneous models that have altered the gene expression of MTOR, MURF-1, or MAFBX in rats and mice. We searched the literature in the following databases: Medline, Scielo.org, Scielo.br, Redib, Lilacs, and the Periodicos Capes. We selected 56 articles for this review. Several conditions can alter the gene expression of muscle proteins under conditions that stimulate muscle degradation pathways. Therefore, treatments must normalize the expression of the degradation pathways and potentiate the synthesis pathways so the muscular tissue confers an increase in functional capacity and thus, survival in diseased patients. Therefore, the reversal of the mechanisms that promote its depletion must be achieved. Identification of the atrophic mechanisms present in pathologies and other conditions of muscular disuse in the scientific literature is fundamental for the adoption of clinical strategies to prevent protein degradation and to promote the maintenance and/or increase of muscle tissue. Such strategies include physical exercise, protein supplementation, and/or pharmacological applications, aimed toward restoring the fullness of functional capacity.
Identifiants
pubmed: 32421985
pii: 478e880265896a53,6c0f15f92c19cbfc
doi: 10.1615/CritRevEukaryotGeneExpr.2020027491
doi:
Substances chimiques
Muscle Proteins
0
Tripartite Motif Proteins
0
Fbxo32 protein, mouse
EC 2.3.2.27
SKP Cullin F-Box Protein Ligases
EC 2.3.2.27
Trim63 protein, rat
EC 2.3.2.27
Ubiquitin-Protein Ligases
EC 2.3.2.27
mTOR protein, mouse
EC 2.7.1.1
TOR Serine-Threonine Kinases
EC 2.7.11.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM